Related Experiment Video
Updated: Aug 25, 2025

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
Published on: January 12, 2017
Accuracy of Paris 2016 System for Non-invasive Diagnosis Bladder Malignancy
Azadeh Rakhshan1, Esmat Arvin1, Sam Alahyari2
1Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Background & Objective:
The Paris System for Reporting Urinary Cytology (TPS) is a new method for evaluating urinary cytology designed to reduce unreproducible reports. The aim of this study was to reclassify and compare urinary cytology reports with TPS criteria to determine the frequency of unreproducible reports compared to the previous system.
Methods:
In this study, the laboratory electronic registration system analyzed patients' urine samples taken by voided or washing and brushing methods. The cytological evaluation was performed considering the previous system and TPS by a pathologist. The results of the two systems were compared, and the sensitivity and specificity of TPS were calculated.
Results:
Urine samples were taken from 876 patients. The mean age of patients was 63.36 ± 12.62. Comparing the routine classification system and TPS, it was observed that the number of atypical reports in the TPS system decreased by 12%, and all of these cases were downgraded to the negative group in the new classification. The sensitivity and specificity of TPS were 29.4% and 95.1%, respectively, if suspected malignancy and positive reports for malignancy were considered. Finally, if positive reports for malignancy were selected, sensitivity and specificity changed to 11.8% and 100%, respectively.
Conclusion:
Although the TPS system has low sensitivity for the diagnosis of urothelial malignancies, due to its high specificity, it is possible to consider and use this classification for screening patients.
Related Concept Videos
Imaging Studies III: Computed Tomography
Imaging Studies VI: Voiding Cystourethrography and Cystography
Imaging Studies V: Intravenous Urography and Retrograde Pyelography

